Sorry, due to rights agreement, we are unable to offer this content in your territory.
By meWATCH Published: 16 May 2020 Audio: English
Singapore is in talks with the US maker of remdesivir on registering the experimental drug here as quickly as possible, to ensure that COVID-19 patients will have continued access to the medicine. Remdesivir, which was created originally to tackle Ebola, has been used on COVID-19 patients as part of clinical trials. Lee Li Ying reports.
Your account has been logged out.
[Error code: 11] Login Unsuccessful, please retry again. If the problem persists, please contact customer care
Please wait. Processing